Nidaan’s AI chest X-ray tool gets approval for a TB screening pilot in Telangana

Nidaan, based in Hyderabad, is the latest example of how health in India is maturing. The move puts the company in a strong position in its segment.

Radiologists will review every scan the tool flags, and the state will compare detection rates with clinics that do not use the software.

Why it matters

Investors across Asia have become more selective since 2023, backing companies that can show paying customers and a clear path to profit. Founders in India told ASN that the bar for a new round now includes at least a year of steady revenue growth.

We built for the customer who was already paying, not the one we hoped would show up.

The company said it will use the next year to deepen its existing markets before expanding further.

The numbers

• Market: India
• Headquarters: Hyderabad
• Sector: Health

What comes next

Competitors are watching closely, and at least two rivals are said to be in talks to raise fresh capital. ASN will keep tracking Nidaan and the wider health market in India.

Have a tip on this story? Email the ASN desk at info@asianstartupnews.com.